AdaptHealth (NASDAQ:AHCO – Get Free Report) had its price target cut by UBS Group from $12.00 to $11.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 23.87% from the stock’s current price.
Several other brokerages have also commented on AHCO. Robert W. Baird lowered their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Canaccord Genuity Group dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Royal Bank of Canada decreased their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research note on Tuesday, November 19th. Finally, Truist Financial dropped their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $12.20.
View Our Latest Report on AdaptHealth
AdaptHealth Stock Down 0.8 %
Institutional Investors Weigh In On AdaptHealth
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AHCO. The Manufacturers Life Insurance Company raised its stake in AdaptHealth by 8.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock worth $394,000 after acquiring an additional 2,959 shares during the period. Louisiana State Employees Retirement System raised its position in shares of AdaptHealth by 30.0% during the third quarter. Louisiana State Employees Retirement System now owns 51,100 shares of the company’s stock valued at $574,000 after buying an additional 11,800 shares during the last quarter. State of Alaska Department of Revenue raised its position in shares of AdaptHealth by 31.5% during the third quarter. State of Alaska Department of Revenue now owns 60,304 shares of the company’s stock valued at $677,000 after buying an additional 14,438 shares during the last quarter. Harbor Capital Advisors Inc. raised its position in shares of AdaptHealth by 142.9% during the third quarter. Harbor Capital Advisors Inc. now owns 449,840 shares of the company’s stock valued at $5,052,000 after buying an additional 264,610 shares during the last quarter. Finally, Amalgamated Bank raised its position in shares of AdaptHealth by 26.7% during the third quarter. Amalgamated Bank now owns 30,916 shares of the company’s stock valued at $347,000 after buying an additional 6,524 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.
About AdaptHealth
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles
- Five stocks we like better than AdaptHealth
- Best Aerospace Stocks Investing
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- What Investors Need to Know About Upcoming IPOs
- CVS Health: Earnings Beat Ignites Stock Rally
- Differences Between Momentum Investing and Long Term Investing
- Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.